Literature DB >> 14885697

A tuberculostatic serum substance possessing lysozyme-like properties.

Q MYRVIK, R S WEISER.   

Abstract

Keywords:  MYCOBACTERIUM TUBERCULOSIS/viability

Mesh:

Substances:

Year:  1951        PMID: 14885697     DOI: 10.1164/art.1951.64.6.669

Source DB:  PubMed          Journal:  Am Rev Tuberc        ISSN: 0096-0381


× No keyword cloud information.
  6 in total

1.  Effect of homogenates of organs from immunized guinea pigs on the respiration of Mycobacterium tuberculosis.

Authors:  A S YOUMANS; G P YOUMANS; A HEGRE
Journal:  J Bacteriol       Date:  1960-09       Impact factor: 3.490

2.  The demonstration of lysozyme as a dominant tuberculostatic factor in extracts of granulomatous lungs.

Authors:  S OSHIMA; Q N MYRVIK; E LEAKE
Journal:  Br J Exp Pathol       Date:  1961-04

3.  An outline of the principal forms of tuberculosis in man; primary, disseminated and bronchogenic tuberculosis.

Authors:  W PAGEL
Journal:  Postgrad Med J       Date:  1952-12       Impact factor: 2.401

4.  Serum and tissue lysozyme in leprosy.

Authors:  T H Rea; C R Taylor
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

5.  The effect of spermine on tubercle bacilli.

Authors:  J G HIRSCH; R J DUBOS
Journal:  J Exp Med       Date:  1952-02       Impact factor: 14.307

6.  Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia.

Authors:  E F Osserman; D P Lawlor
Journal:  J Exp Med       Date:  1966-11-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.